Skip to Main Content

Author Details

Ze'ev Ronai
Cancer Center, Sanford Burnham Prebys Medical Discovery Institute
1981
319
81
Trey Ideker (CM4AI)
PMIDPaper TitleJournal TitlePublished Year
36513065Clinically oriented prediction of patient response to targeted and immunotherapies from the tumor transcriptome.Med2023
36513065Clinically oriented prediction of patient response to targeted and immunotherapies from the tumor transcriptome.Med2023
37406115Melanoma-intrinsic NR2F6 activity regulates antitumor immunity.Sci Adv2023
37078793Ubiquitin Ligases Siah1a/2 Control Alveolar Macrophage Functions to Limit Carcinogen-Induced Lung Adenocarcinoma.Cancer Res2023
37425866RNF185 control of COL3A1 expression limits prostate cancer migration and metastatic potential.bioRxiv2023
37425866RNF185 control of COL3A1 expression limits prostate cancer migration and metastatic potential.bioRxiv2023
37078793Ubiquitin Ligases Siah1a/2 Control Alveolar Macrophage Functions to Limit Carcinogen-Induced Lung Adenocarcinoma.Cancer Res2023
37406115Melanoma-intrinsic NR2F6 activity regulates antitumor immunity.Sci Adv2023
36050469NRF2 mediates melanoma addiction to GCDH by modulating apoptotic signalling.Nat Cell Biol2022
35577818Author Correction: A systematic genome-wide mapping of oncogenic mutation selection during CRISPR-Cas9 genome editing.Nat Commun2022
35561126Arginyl-tRNA-protein transferase 1 (ATE1) promotes melanoma cell growth and migration.FEBS Lett2022
36050469NRF2 mediates melanoma addiction to GCDH by modulating apoptotic signalling.Nat Cell Biol2022
36532738Inhibition of coronavirus HCoV-OC43 by targeting the eIF4F complex.Front Pharmacol2022
35577818Author Correction: A systematic genome-wide mapping of oncogenic mutation selection during CRISPR-Cas9 genome editing.Nat Commun2022
35561126Arginyl-tRNA-protein transferase 1 (ATE1) promotes melanoma cell growth and migration.FEBS Lett2022
36532738Inhibition of coronavirus HCoV-OC43 by targeting the eIF4F complex.Front Pharmacol2022
33406406Harnessing the Co-vulnerabilities of Amino Acid-Restricted Cancers.Cell Metab2021
33545064Melanoma models for the next generation of therapies.Cancer Cell2021
33857424Synthetic lethality-mediated precision oncology via the tumor transcriptome.Cell2021
33632871Identification and Characterization of IMD-0354 as a Glutamine Carrier Protein Inhibitor in Melanoma.Mol Cancer Ther2021
34140316IL-6 contributes to metastatic switch via the differentiation of monocytic-dendritic progenitors into prometastatic immune cells.J Immunother Cancer2021
33554439MAPK signaling regulates c-MYC for melanoma cell adaptation to asparagine restriction.EMBO Rep2021
33406406Harnessing the Co-vulnerabilities of Amino Acid-Restricted Cancers.Cell Metab2021
34518534The ubiquitin ligase RNF5 determines acute myeloid leukemia growth and susceptibility to histone deacetylase inhibitors.Nat Commun2021
34462276Neural Crest-Like Stem Cell Transcriptome Analysis Identifies LPAR1 in Melanoma Progression and Therapy Resistance.Cancer Res2021
34764240A systematic genome-wide mapping of oncogenic mutation selection during CRISPR-Cas9 genome editing.Nat Commun2021
34642948Lipid metabolism: new twists to the Yin and Yang of PKM2 in cancer.EMBO J2021
33545064Melanoma models for the next generation of therapies.Cancer Cell2021
33554439MAPK signaling regulates c-MYC for melanoma cell adaptation to asparagine restriction.EMBO Rep2021
33857424Synthetic lethality-mediated precision oncology via the tumor transcriptome.Cell2021
33632871Identification and Characterization of IMD-0354 as a Glutamine Carrier Protein Inhibitor in Melanoma.Mol Cancer Ther2021
34764240A systematic genome-wide mapping of oncogenic mutation selection during CRISPR-Cas9 genome editing.Nat Commun2021
34642948Lipid metabolism: new twists to the Yin and Yang of PKM2 in cancer.EMBO J2021
34518534The ubiquitin ligase RNF5 determines acute myeloid leukemia growth and susceptibility to histone deacetylase inhibitors.Nat Commun2021
34462276Neural Crest-Like Stem Cell Transcriptome Analysis Identifies LPAR1 in Melanoma Progression and Therapy Resistance.Cancer Res2021
34140316IL-6 contributes to metastatic switch via the differentiation of monocytic-dendritic progenitors into prometastatic immune cells.J Immunother Cancer2021
32540455Unfolded Protein Response in Leukemia: From Basic Understanding to Therapeutic Opportunities.Trends Cancer2020
31911617Siah2 control of T-regulatory cells limits anti-tumor immunity.Nat Commun2020
31733993Lineage-Restricted Regulation of SCD and Fatty Acid Saturation by MITF Controls Melanoma Phenotypic Plasticity.Mol Cell2020
32360601Regulation of eIF2α by RNF4 Promotes Melanoma Tumorigenesis and Therapy Resistance.J Invest Dermatol2020
32049008Prebiotic-Induced Anti-tumor Immunity Attenuates Tumor Growth.Cell Rep2020
32392217Correction: Regulation of ATG4B Stability by RNF5 Limits Basal Levels of Autophagy and Influences Susceptibility to Bacterial Infection.PLoS Genet2020
31816571The gut microbiome: an unexpected player in cancer immunity.Curr Opin Neurobiol2020
32540455Unfolded Protein Response in Leukemia: From Basic Understanding to Therapeutic Opportunities.Trends Cancer2020
32641491PRMT5 control of cGAS/STING and NLRC5 pathways defines melanoma response to antitumor immunity.Sci Transl Med2020
32743345PRMT5 function and targeting in cancer.Cell Stress2020
32571981SPANX Control of Lamin A/C Modulates Nuclear Architecture and Promotes Melanoma Growth.Mol Cancer Res2020
32839770SARS-CoV-2 ORF9c Is a Membrane-Associated Protein that Suppresses Antiviral Responses in Cells.bioRxiv2020
33321081Takashi Sugimura (1926-2020).Cancer Cell2020
31816571The gut microbiome: an unexpected player in cancer immunity.Curr Opin Neurobiol2020
  • 1 - 50 of 638

Recommended Authors

Rahul Kumar
Roswell Park Comprehensive Cancer Center
Career Start Year 2009
Number of shared co-authors 0
Young K Song
National Cancer Institute, National Institutes of Health
Career Start Year 2007
Number of shared co-authors 6
Genevi??ve Lavoie
Institute for Research in Immunology and Cancer (IRIC)
Career Start Year 2004
Number of shared co-authors 1
Bin Yan
The University of Hong Kong
Career Start Year 2003
Number of shared co-authors 2
Barak Rotblat
Ben-Gurion University of the Negev
Career Start Year 2002
Number of shared co-authors 2
Ina Poser
Max Planck Institute of Molecular Cell Biology and Genetics
Career Start Year 2001
Number of shared co-authors 1
Rachel Toth
University of Dundee
Career Start Year 1999
Number of shared co-authors 4
Chandra C Ghosh
The Wistar Institute
Career Start Year 1999
Number of shared co-authors 3
Jianjun Shen
The University of Texas MD Anderson Cancer Center
Career Start Year 1998
Number of shared co-authors 7
Yaoqi Alan Wang
The University of Texas MD Anderson Cancer Center
Career Start Year 1997
Number of shared co-authors 1
Dongquan Chen
University of Alabama at Birmingham
Career Start Year 1997
Number of shared co-authors 0
Jose Antonio Rodriguez
University of the Basque Country (UPV/EHU)
Career Start Year 1995
Number of shared co-authors 1
John Alan Diehl
Case Western Reserve University School of Medicine
Career Start Year 1993
Number of shared co-authors 9
William Clark
Cancer Research UK Beatson Institute
Career Start Year 1993
Number of shared co-authors 6
Christoph Reinhard
Lilly Research Laboratories
Career Start Year 1992
Number of shared co-authors 1
Wenbin Wei
Sheffield Institute for Translational Neuroscience (SITraN), University of Sheffield
Career Start Year 1991
Number of shared co-authors 0
Peter D Adams
Sanford Burnham Prebys Medical Discovery Institute
Career Start Year 1991
Number of shared co-authors 10
Suzanne Carreira
The Institute of Cancer Research
Career Start Year 1990
Number of shared co-authors 2
Dirk Geerts
Amsterdam University Medical Center
Career Start Year 1989
Number of shared co-authors 0
Qimin Zhan
Peking University Cancer Hospital
Career Start Year 1989
Number of shared co-authors 2
Wei Zhang
The University of Texas MD Anderson Cancer Center
Career Start Year 1988
Number of shared co-authors 4
William C Hahn
Broad Institute of MIT and Harvard, USA Dana-Farber Cancer Institute
Career Start Year 1987
Number of shared co-authors 12
Rakesh Kumar
Rutgers New Jersey Medical School
Career Start Year 1987
Number of shared co-authors 11
Daniel S Peeper
Netherlands Cancer Institute
Career Start Year 1987
Number of shared co-authors 9
Stephen J Elledge
Howard Hughes Medical Institute, Brigham and Women's Hospital, Harvard Medical School
Career Start Year 1982
Number of shared co-authors 5
J. Wade Harper
Harvard Medical School
Career Start Year 1981
Number of shared co-authors 10
Francisca Vazquez
Broad Institute of MIT and Harvard
Career Start Year 1979
Number of shared co-authors 3
Chi V Dang
Johns Hopkins University School of Medicine
Career Start Year 1978
Number of shared co-authors 5
Frank McCormick
Frederick National Laboratory for Cancer Research
Career Start Year 1975
Number of shared co-authors 10
Norman E Sharpless
National Cancer Institute
Career Start Year 1945
Number of shared co-authors 7

Collaborators

Yongmei Feng
Cancer Center, Sanford Burnham Prebys Medical Discovery Institute
Co-authored papers 30
Anindita Bhoumik
Burnham Institute for Medical Research
Co-authored papers 26
Hyungsoo Kim
Sungkyunkwan University
Co-authored papers 20
Eric Lau
Moffitt Cancer Center
Co-authored papers 16
Marzia Scortegagna
NCI-Designated Cancer Center, Sanford Burnham Prebys Medical Discovery Institute
Co-authored papers 13
Meenhard Herlyn
Ellen and Ronald Caplan Cancer Center, The Wistar Institute
Co-authored papers 12
Eytan Ruppin
National Cancer Institute
Co-authored papers 12
David D L Bowtell
Peter MacCallum Cancer Centre
Co-authored papers 11
David A Scott
Sanford Burnham Prebys Medical Discovery Institute
Co-authored papers 11
Marcus Bosenberg
Yale School of Medicine
Co-authored papers 10
Harriet M Kluger
Yale School of Medicine
Co-authored papers 10
Stan Krajewski
Cellstan-Immunoquant Inc.
Co-authored papers 10
Ivan Topisirovic
McGill University
Co-authored papers 9
Pedro Aza-Blanc
Sanford-Burnham-Prebys Medical Discovery Institute
Co-authored papers 8
Andrei L Osterman
Sanford Burnham Prebys Medical Discovery Institute
Co-authored papers 8
Brian James
Cancer Center, Sanford Burnham Prebys Medical Discovery Institute
Co-authored papers 8
Rabi Murad
Sanford Burnham Prebys Medical Discovery Institute
Co-authored papers 6
Reinhard Dummer
University Hospital Zurich
Co-authored papers 5
Nic Jones
Cancer Research United Kingdom Manchester Institute, University of Manchester
Co-authored papers 5
Giuseppina Claps
Institut National de la Sante et de la Recherche Medicale (INSERM) U
Co-authored papers 5
Tal Varsano
Sanford-Burnham Medical Research Institute
Co-authored papers 5
Shu-Ichi Matsuzawa
Co-authored papers 4
Aniruddha J Deshpande
Sanford Burnham Prebys Medical Discovery Institute
Co-authored papers 4
Mikhail A Krasil'nikov
Blokhin N.N. National Medical Research Center of Oncology
Co-authored papers 4
Menashe Bar-Eli
The University of Texas MD Anderson Cancer Center
Co-authored papers 3
Kenneth D Bromberg
Co-authored papers 3
Anthony B Pinkerton
Sanford Burnham Prebys Medical Discovery Institute
Co-authored papers 3
David L Rimm
Yale University School of Medicine
Co-authored papers 3
Eduard Sergienko
Cancer Center, Sanford Burnham Prebys Medical Discovery Institute
Co-authored papers 3
Toru Fukushima
Co-authored papers 3
Release 1.2